Journal
TRENDS IN GENETICS
Volume 25, Issue 3, Pages 137-146Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tig.2009.01.001
Keywords
-
Categories
Funding
- National Institutes of Allergy and Infectious Diseases [AI065687, A1067152]
- National Institute of Diabetes and Digestive and Kidney Diseases [DK064869, DK062432]
- Crohn's and Colitis Foundation of America [SRA512]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065687, U19AI067152] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062432, R01DK064869] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Genome-wide association (GWA) studies are substantially improving our understanding of the molecular pathways leading to inflammatory bowel diseases (IBD). This is a result of the nature of these studies, which are comprehensive - leading to a dramatic increase in the number of validated genetic risk factors - and unbiased - leading to the identification of novel pathways not previously suspected in IBD. Such discoveries are not only driving the functional studies to understand the mechanisms by which genetic variants modify an individual's susceptibility to disease, but also hold the promise of guiding the development of more effective treatment strategies. In this review, we discuss how GWA studies are enabling us to rewrite the story of IBD pathogenesis, focusing on the interleukin-23 and autophagy pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available